Franklin Resources’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1M | Buy |
278,510
+51,995
| +23% | +$5.43M | 0.01% | 808 |
|
|
2025
Q1 | $26.4M | Buy |
226,515
+44,225
| +24% | +$5.16M | 0.01% | 818 |
|
|
2024
Q4 | $15.4M | Buy |
182,290
+21,756
| +14% | +$1.84M | ﹤0.01% | 976 |
|
|
2024
Q3 | $13.7M | Buy |
160,534
+51,696
| +47% | +$4.42M | ﹤0.01% | 1008 |
|
|
2024
Q2 | $8.76M | Buy |
108,838
+967
| +0.9% | +$77.8K | ﹤0.01% | 1121 |
|
|
2024
Q1 | $8.61M | Buy |
107,871
+104,325
| +2,942% | +$8.33M | ﹤0.01% | 1135 |
|
|
2023
Q4 | $282K | Buy |
3,546
+11
| +0.3% | +$875 | ﹤0.01% | 2198 |
|
|
2023
Q3 | $247K | Sell |
3,535
-1,306
| -27% | -$91.3K | ﹤0.01% | 2230 |
|
|
2023
Q2 | $348K | Buy |
4,841
+1,498
| +45% | +$108K | ﹤0.01% | 2132 |
|
|
2023
Q1 | $206K | Buy |
3,343
+591
| +21% | +$36.5K | ﹤0.01% | 1988 |
|
|
2022
Q4 | $212K | Buy |
+2,752
| New | +$212K | ﹤0.01% | 1985 |
|